290 related articles for article (PubMed ID: 16399958)
1. Best practices: An initiative to curtail the use of antipsychotic polypharmacy in a state psychiatric hospital.
Patrick V; Schleifer SJ; Nurenberg JR; Gill KJ
Psychiatr Serv; 2006 Jan; 57(1):21-3. PubMed ID: 16399958
[TBL] [Abstract][Full Text] [Related]
2. Variation in long-term antipsychotic polypharmacy and high-dose prescribing across physicians and hospitals.
Latimer EA; Naidu A; Moodie EE; Clark RE; Malla AK; Tamblyn R; Wynant W
Psychiatr Serv; 2014 Oct; 65(10):1210-7. PubMed ID: 24981557
[TBL] [Abstract][Full Text] [Related]
3. Psychotropic prescribing in seriously violent men with schizophrenia or personality disorder in a UK high security hospital.
Stone-Brown K; Naji M; Francioni A; Myers K; Samarendra H; Mushtaq-Chaudhry H; Heslop S; Sengupta S; Ross CC; Larkin F; Das M
CNS Spectr; 2016 Feb; 21(1):60-9. PubMed ID: 26726766
[TBL] [Abstract][Full Text] [Related]
4. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
Bret P; Bret MC; Queuille E
Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
[TBL] [Abstract][Full Text] [Related]
5. Antipsychotic Medication Prescribing Practices Among Adult Patients Discharged From State Psychiatric Inpatient Hospitals.
Ortiz G; Hollen V; Schacht L
J Psychiatr Pract; 2016 Jul; 22(4):283-97. PubMed ID: 27427840
[TBL] [Abstract][Full Text] [Related]
6. Medical decision making in antipsychotic drug choice for schizophrenia.
Hamann J; Langer B; Leucht S; Busch R; Kissling W
Am J Psychiatry; 2004 Jul; 161(7):1301-4. PubMed ID: 15229068
[TBL] [Abstract][Full Text] [Related]
7. Prescription practices in the treatment of agitation in newly hospitalized Chinese schizophrenia patients: data from a non-interventional naturalistic study.
Zhang SZ; Mu YG; Liu Q; Shi Y; Guo LH; Li LZ; Yang FD; Wang Y; Li T; Mei QY; He HB; Chen ZY; Su ZH; Liu TB; Xie SP; Tan QR; Zhang JB; Zhang CP; Sang H; Mi WF; Zhang HY
BMC Psychiatry; 2019 Jul; 19(1):216. PubMed ID: 31291931
[TBL] [Abstract][Full Text] [Related]
8. Determinants of antipsychotic polypharmacy in psychiatric inpatients: a prospective study.
Biancosino B; Barbui C; Marmai L; Donà S; Grassi L
Int Clin Psychopharmacol; 2005 Nov; 20(6):305-9. PubMed ID: 16192838
[TBL] [Abstract][Full Text] [Related]
9. Prevalence, trends, and factors associated with antipsychotic polypharmacy among Medicaid-eligible schizophrenia patients, 1998-2000.
Ganguly R; Kotzan JA; Miller LS; Kennedy K; Martin BC
J Clin Psychiatry; 2004 Oct; 65(10):1377-88. PubMed ID: 15491242
[TBL] [Abstract][Full Text] [Related]
10. Variations in prescribing practices for novel antipsychotic medications among Veterans Affairs hospitals.
Owen RR; Feng W; Thrush CR; Hudson TJ; Austen MA
Psychiatr Serv; 2001 Nov; 52(11):1523-5. PubMed ID: 11684751
[TBL] [Abstract][Full Text] [Related]
11. [Use of atypical antipsychotics in Charles Perrens psychiatric hospital (Bordeaux) analysis of prescribing practices for Amisulpride, Clozapine, Olanzapine and Risperidone].
Bret P; Bonnet F; Bret MC; Jaffré A
Encephale; 2002; 28(4):329-42. PubMed ID: 12232542
[TBL] [Abstract][Full Text] [Related]
12. Best practices: racial and ethnic effects on antipsychotic prescribing practices in a community mental health center.
Woods SW; Sullivan MC; Neuse EC; Diaz E; Baker CB; Madonick SH; Griffith EE; Steiner JL
Psychiatr Serv; 2003 Feb; 54(2):177-9. PubMed ID: 12556597
[No Abstract] [Full Text] [Related]
13. National trends in psychotropic medication polypharmacy in office-based psychiatry.
Mojtabai R; Olfson M
Arch Gen Psychiatry; 2010 Jan; 67(1):26-36. PubMed ID: 20048220
[TBL] [Abstract][Full Text] [Related]
14. Effect of clozapine on polypharmacy.
Chong SA; Remington GJ; Bezchlibnyk-Butler KZ
Psychiatr Serv; 2000 Feb; 51(2):250-2. PubMed ID: 10655014
[TBL] [Abstract][Full Text] [Related]
15. The prevalence of antipsychotic polypharmacy in schizophrenic patients discharged from psychiatric units in Poland.
Jaracz J; Tetera-Rudnicka E; Kujath D; Raczyńska A; Stoszek S; Czernaś W; Wierzbiński P; Moniakowski A; Jaracz K; Rybakowski J
Pharmacol Rep; 2014 Aug; 66(4):613-7. PubMed ID: 24948062
[TBL] [Abstract][Full Text] [Related]
16. Prescribing patterns for inpatients with schizophrenia spectrum disorders in a psychiatric hospital in Slovenia: Results of 16-month prospective, non-interventional clinical research.
Bole CB; Pišlar M; Mrhar A; Tavčar R
Psychiatr Danub; 2017 Jun; 29(2):155-161. PubMed ID: 28636573
[TBL] [Abstract][Full Text] [Related]
17. Is higher psychotropic medication burden associated with involuntary treatment under the Mental Health Act? A four-year Australian cohort study.
Wheeler AJ; Hu J; Profitt C; McMillan SS; Theodoros T
BMC Psychiatry; 2020 Jun; 20(1):294. PubMed ID: 32527250
[TBL] [Abstract][Full Text] [Related]
18. Development and delivery of a quality improvement program to reduce antipsychotic polytherapy.
Gören JL; Beck SE; Mills BJ; Shtasel DL; Dufresne RL
J Manag Care Pharm; 2010; 16(6):393-401. PubMed ID: 20635830
[TBL] [Abstract][Full Text] [Related]
19. Patient characteristics and process factors associated with antipsychotic polypharmacy in a nationwide sample of psychiatric inpatients in Italy.
Santone G; Bellantuono C; Rucci P; Picardi A; Preti A; de Girolamo G
Pharmacoepidemiol Drug Saf; 2011 May; 20(5):441-9. PubMed ID: 21523847
[TBL] [Abstract][Full Text] [Related]
20. Antipsychotic polypharmacy: a survey of discharge prescriptions from a tertiary care psychiatric institution.
Procyshyn RM; Kennedy NB; Tse G; Thompson B
Can J Psychiatry; 2001 May; 46(4):334-9. PubMed ID: 11387789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
